Please check your internet connection and try again.
# Potassium Chloride
## Overview
Potassium chloride (KCl) is an essential electrolyte used to treat and prevent hypokalemia. It is available in oral and intravenous formulations.
## Primary Indications
* Treatment of hypokalemia.
* Prevention of hypokalemia in patients at risk.
## Adult Dosing
* **Treatment of hypokalemia:**
* Oral: Typically 20-60 mEq per day in divided doses. Doses up to 100-200 mEq per day may be needed in severe cases, but require close monitoring.
* Intravenous (IV): Typical dose is 10-20 mEq per hour. Doses exceeding 20 mEq per hour should only be administered in critical care settings with continuous cardiac monitoring. Maximum total daily dose is generally 200 mEq.
* **Prevention of hypokalemia:**
* Oral: Typically 20-40 mEq per day.
*Note: Specific dosing often depends on serum potassium levels, degree of deficit, and clinical condition. Local protocols may dictate specific dosing strategies, especially for IV administration.*
## Pediatric Dosing
* **Treatment of hypokalemia:**
* Oral: 1-3 mEq/kg per day in divided doses, not to exceed 20 mEq per day.
* Intravenous (IV): 0.5-1 mEq/kg per dose, infused at a rate not exceeding 0.5-1 mEq/kg/hour (maximum 20 mEq/hour). Maximum total daily dose is generally 3 mEq/kg or 200 mEq, whichever is less.
* **Prevention of hypokalemia:**
* Oral: 1 mEq/kg per day, not to exceed 40 mEq per day.
*Note: Pediatric IV potassium chloride infusion rates must be strictly adhered to due to the risk of cardiac arrhythmias. Pediatric dosing requires careful calculation and monitoring.*
## Dose Adjustments
* **Renal Impairment:** Potassium chloride should be used with extreme caution or avoided in patients with significant renal impairment due to the risk of hyperkalemia. Dose reduction or discontinuation may be necessary.
## Contraindications
* Hyperkalemia.
* Conditions that predispose to hyperkalemia (e.g., severe renal impairment, untreated Addison's disease, certain crush injuries).
* Concurrent use of potassium-sparing diuretics or ACE inhibitors/ARBs in patients with elevated potassium levels.
## Adverse Effects
* **Common:** Nausea, vomiting, diarrhea, abdominal discomfort.
* **Serious:** Hyperkalemia (most significant risk), cardiac arrhythmias (especially with rapid IV infusion or in patients with underlying cardiac disease), esophageal or gastric irritation/perforation (with oral formulations, especially without adequate fluid).
## Key Drug Interactions
* **Potassium-sparing diuretics (e.g., spironolactone, amiloride), ACE inhibitors (e.g., lisinopril), ARBs (e.g., losartan), NSAIDs:** Increased risk of hyperkalemia.
* **Digoxin:** Hyperkalemia can increase digoxin toxicity. Hypokalemia can decrease digoxin's effectiveness and increase toxicity.
* **Neuromuscular blocking agents:** Potassium can affect neuromuscular transmission.
## Monitoring
* **Serum potassium levels:** Frequently monitor, especially during initiation of therapy, dose changes, and in patients with renal impairment.
* **Electrocardiogram (ECG):** Monitor for signs of hyperkalemia (e.g., peaked T waves, widened QRS complex) especially with IV administration or in patients at risk.
* **Renal function:** Monitor serum creatinine and BUN.
* **Signs and symptoms of hypokalemia or hyperkalemia.**
## Clinical Pearls
* Oral potassium chloride should be taken with food or fluids to minimize gastrointestinal upset and irritation.
* IV potassium chloride must be diluted and infused slowly; never give as an IV bolus.
* Rapid IV administration of potassium can be fatal.
* Ensure adequate hydration and urine output when administering potassium.
* Consider the potassium content of other medications and IV fluids.
***
*Disclaimer: This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant guidelines before making any treatment decisions.*
